| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |